What is Apnea Sciences?
Apnea Sciences Corporation is a specialized entity focused on the design, development, manufacturing, and distribution of innovative products for snoring and sleep apnea treatment. Their portfolio includes precision-engineered, comfortable oral appliances such as the FDA-cleared SnoreRx and ApneaRx. By providing healthcare professionals with high-quality, consistent-outcome tools, Apnea Sciences aims to enhance sleep medicine and offer effective therapeutic alternatives to conventional methods, thereby improving the quality of life for individuals affected by sleep disorders.
How much funding has Apnea Sciences raised?
Apnea Sciences has raised a total of $60K across 1 funding round:
Debt
$60K
Debt (2021): $60K with participation from PPP
What's next for Apnea Sciences?
With substantial expansion capital secured, Apnea Sciences is poised for significant growth. The recent financing is expected to fuel advancements in product development, manufacturing capabilities, and market reach. This strategic investment will likely enable the company to scale its operations, potentially explore new therapeutic areas within sleep medicine, and further solidify its position as a key provider of sleep disorder solutions. The company's trajectory suggests a focus on broadening access to its innovative sleep apnea and snoring treatments.
See full Apnea Sciences company page
